AvenCell
Based on our deep science and focused on patients in need.
$112M Series B+ ·
Led by Novo Holdings · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredJul 27, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $112M | fundraisingfox.com |
Timeline
- Website created
Founders and team
AD
Andrew D. Schiermeier FounderGE
Gerhard Ehninger Chief Medical OfficerJF
James Feliciano Fractional General ManagerMO
Markus Orchowski Vice President Operations
Investors
AAMED
BBlackstone Life Sciences
EEight Roads Ventures Japan
FF-Prime Capital
LLigand Pharmaceuticals
NNovo Holdingslead investor
NNYBC Ventures
PPiper Heartland Healthcare Capital
Companies like AvenCell
OOpenEvidence$250M Series B+ · Sep 2026
DDandelion Health$14M Series A · May 2026
FFeldan TherapeuticsSeries B+ · Sep 2024HHippocratic AI$126M Series B+ · Nov 2025
EEyebot$20M Series A · Aug 2025
SSeroba LifesciencesSeries A · Sep 2024
Other companies backed by Novo Holdings
OOMass Therapeutics$310M Series B+ · Oct 2026
AAnaCardio$70.97M Series B+ · Sep 2026
BBreye Therapeutics$76.65M Series A · Sep 2026
CClaris Bio$118M Series B+ · Jul 2026
BBactolife$34.9M Series B+ · Jan 2026
SSidera Bio$109.99M Series A · Nov 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/avencell (get a free API key).